BRIEF published on 04/30/2024 at 11:05, 2 years 3 months ago New Partnership Between BioMed X Institute and Merck Focuses on Immuno-Oncology Cancer Research BioMed X Institute Immunotherapy Merck Tumor Immunogenicity
PRESS RELEASE published on 04/30/2024 at 11:00, 2 years 3 months ago New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg Biomedical research institute, BioMed X, partners with Merck to develop novel immunotherapeutic strategies to enhance tumor immunogenicity for cancer patients Cancer Research Immunotherapy Merck Tumor Immunogenicity BioMed X
PRESS RELEASE published on 02/06/2024 at 16:00, 2 years 6 months ago New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine BioMed X Institute and Universitatsmedizin Mannheim researchers publish results of collaboration on new neoepitope vaccine in diffuse midline glioma in Science Advances BioMed X Institute Universitatsmedizin Mannheim Neoepitope Vaccine Diffuse Midline Glioma Science Advances
PRESS RELEASE published on 11/07/2023 at 12:00, 2 years 9 months ago BioMed X Launches a New Call for Application in Autoimmune Disease Research
PRESS RELEASE published on 10/31/2023 at 17:00, 2 years 9 months ago BioMed X and AbbVie Start New Research Project in the USA
PRESS RELEASE published on 06/29/2023 at 11:00, 3 years 1 month ago BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
PRESS RELEASE published on 04/27/2023 at 14:00, 3 years 3 months ago BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
PRESS RELEASE published on 04/04/2023 at 11:00, 3 years 4 months ago BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Published on 08/15/2026 at 00:50, 10 hours 27 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 11 hours 2 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 11 hours 32 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 11 hours 52 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 12 hours 17 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 3 hours 12 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 17 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 19 hours 12 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 17 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 17 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 17 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 17 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
